$ASNS X4 Pharmaceuticals, Inc Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in X4 Pharmaceuticals, Inc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in X4 Pharmaceuticals, Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in X4 Pharmaceuticals, Inc for free.

CIK Number: 0001501697
IRS Number: 273181608
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ASNS
Company Address: 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE 02139
Phone number: 781-819-5704
Former name: Arsanis, Inc., date of change: 2010-09-20

X4 Pharmaceuticals, Inc Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BLECH ISAACDirector00Mar 14 20196 days ago
Bridger GaryDirector00Mar 14 20196 days ago
Mostafa Adam S.See Remarks00Mar 14 20196 days ago
Ragan PaulaPresident and CEO181,3660shares bought: 181,366 / shares sold: 0 BUYMar 14 20196 days ago
WYZGA MICHAEL SDirector00Mar 14 20196 days ago

View all X4 Pharmaceuticals, Inc insiders.

X4 Pharmaceuticals, Inc Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA7.0880,160567,53380,160
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA6.8465,430447,54165,430
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA6.84100,729688,986100,729
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOGrantA0.00181,3660181,3660 to 181.4 K
Mar 14 2019ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA10.4421,570225,19121,570
Mar 14 2019ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA10.4421,570225,19121,570
Mar 14 2019ASNSX4 Pharmaceuticals ...BLECH ISAACDirectorOption ExerciseA6.8470,796484,24570,796
Mar 14 2019ASNSX4 Pharmaceuticals ...BLECH ISAACDirectorOption ExerciseA6.8470,796484,24570,796
Mar 14 2019ASNSX4 Pharmaceuticals ...WYZGA MICHAEL SDirectorOption ExerciseA10.4470,324734,18370,324
Mar 14 2019ASNSX4 Pharmaceuticals ...WYZGA MICHAEL SDirectorOption ExerciseA10.4470,324734,18370,324
Mar 14 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksOption ExerciseA10.4462,633653,88962,633
Mar 14 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksOption ExerciseA10.4462,633653,88962,633
Nov 28 2018ASNSArsanis, Inc.GRAY MICHAELPresident, CEO and ...GrantA0.00250,0000250,0000 to 250 K
Nov 28 2018ASNSArsanis, Inc.GRAY MICHAELPresident, CEO and ...GrantA0.00250,0000250,0000 to 250 K
Jun 07 2018ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseA16.9910,000169,90010,000

View all X4 Pharmaceuticals, Inc insider transactions.